Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Better than all the rest...
View:
Post by wildbird1 on Dec 16, 2024 7:29pm

Better than all the rest...

Video;
Theralase Technologies With President & CEO, Roger Dumoulin-White | December 16th, 2024 | Watch

About TLT treatment.
At the 2:19 time...
R.Dumoulin said''Even for the treatments coming down the pipe(competition), ours data are as strong or stronger than them, and TLT treatment doesn't have the restrictions they do, because some of them, they have to have certain protein in the bladder cancer, some have to have certain markers, we don't have any of that, we treat all patients, all comers and our data are world class''.

What I retain from this video is, TLT treat 100% of patients no other treatment treat 100% of patients, and TLT treatment is 100% safe no other treatment is 100% safe, and TLT treatment has better duration of response data than all the competition.

The $value of the above for a Big Pharma deal is big, very big.


.
Comment by StevenBirch on Dec 16, 2024 7:40pm
Yes the message is changing a little, they seem to be really going on offense. BTD seems inevitable at this point and that is really just the beginning.
Comment by Legit62 on Dec 16, 2024 7:47pm
wildbird1 i would go a step further and say the value to BIG PHARMA is not big, it is huge with all the indications we have moving foward. Just need to ge there
Comment by Galaxym31 on Dec 16, 2024 7:55pm
Can we move onto brain cancer a horrible death sentence for so many  as I type.Do no harm to me in the case of brain cancer means not trying.
Comment by BlueFranky on Dec 16, 2024 9:41pm
Did you catch that canary that swallowed the bird grin on Roger's face? .. anybody else get the feeling we're about to receive some kind of good news?  I do!
Comment by toade1313 on Dec 17, 2024 1:47am
Or was it: The canary (TLT) swallowed the cat (Big Pharma). RDW did look very happy!!!
Comment by reconsider on Dec 17, 2024 3:01pm
The fact that he is finally doing a vid with a blazzer on gives me indubitable confidence on what it is about to come. It's BTD season.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250